Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02310724 · ClinicalTrials.gov registry record
TODAY2 Phase 2 Follow-up
A clinical trial, sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).
- Completed
- Registry status
- 517
- Enrollment target
NCT02310724 is a clinical trial that has completed, run by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). The registered enrollment target is 517 participants.
The verdict
NCT02310724 has completed, sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).
- COMPLETED
- Registry status
- 517 participants
- Enrollment target
Study Summary
The primary objective of T2P2 is to track the progression of T2D and related comorbidities and complications in the TODAY cohort as they transition to young adulthood. We hypothesize that: * Youth-onset type 2 diabetes (T2D) will progress rapidly and result in high rates of diabetes-related medical complications and comorbidities. * The rapid rate of progression is related to increased insulin resistance characteristic of puberty, worse β-cell function, degree of glycemic control, control of non-glycemic factors, and obesity itself.
Interventions
- OTHER TODAY cohort
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 517 participants |
| Start Date | 2014-03-01 |
| Est. Completion | 2020-01-17 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02310724
The ClinicalTrials.gov registry entry for NCT02310724 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 517 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), which has 490 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which TODAY cohort is the first listed.
NCT02310724 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02310724 about?
NCT02310724 is a clinical study titled "TODAY2 Phase 2 Follow-up". The primary objective of T2P2 is to track the progression of T2D and related comorbidities and complications in the TODAY cohort as they transition to young adulthood. We hypothesize that: * Youth-onset type 2 diabetes (T2D) will progress rapidly and result in high rates of diabetes-related medical...
What is the current status of trial NCT02310724?
This trial is currently completed. The enrollment target is 517 participants. The study started on 2014-03-01. Estimated completion is 2020-01-17.
What interventions are being tested in trial NCT02310724?
The interventions under investigation include: TODAY cohort (OTHER).
Who is sponsoring clinical trial NCT02310724?
This trial is sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), which has 490 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.